Josh Lauring

4.1k total citations
42 papers, 2.0k citations indexed

About

Josh Lauring is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Josh Lauring has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Josh Lauring's work include PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer Genomics and Diagnostics (8 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Josh Lauring is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer Genomics and Diagnostics (8 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Josh Lauring collaborates with scholars based in United States, Spain and Netherlands. Josh Lauring's co-authors include Ben Ho Park, Mark S. Schlissel, John P. Gustin, Joseph P. Garay, Kyung Hee Yi, Abde M. Abukhdeir, Hiroyuki Konishi, Antonio C. Wolff, Xiaobing Shi and Barry M. Zee and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Josh Lauring

41 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Josh Lauring United States	22	1.4k	515	510	272	247	42	2.0k
Kienan I. Savage United Kingdom	20	1.6k 1.1×	739 1.4×	339 0.7×	191 0.7×	259 1.0×	44	2.1k
Yanis Boumber United States	22	1.6k 1.1×	699 1.4×	471 0.9×	420 1.5×	192 0.8×	56	2.3k
T. Khanh United States	26	1.6k 1.2×	991 1.9×	473 0.9×	462 1.7×	238 1.0×	57	2.5k
Michael Milyavsky Israel	23	1.5k 1.1×	725 1.4×	456 0.9×	148 0.5×	251 1.0×	47	2.1k
Tim Hon Man Chan United States	31	1.8k 1.3×	647 1.3×	489 1.0×	137 0.5×	648 2.6×	66	2.7k
Simonetta Buglioni Italy	22	930 0.7×	772 1.5×	511 1.0×	227 0.8×	188 0.8×	71	1.7k
Kevin Kwei United States	17	907 0.6×	598 1.2×	412 0.8×	216 0.8×	161 0.7×	27	1.6k
Peter Horak Germany	20	1.2k 0.9×	457 0.9×	590 1.2×	242 0.9×	235 1.0×	68	1.9k
Esra A. Akbay United States	23	910 0.6×	582 1.1×	299 0.6×	196 0.7×	292 1.2×	34	1.6k
Nandini Dey United States	25	1.4k 1.0×	907 1.8×	432 0.8×	365 1.3×	164 0.7×	71	2.1k

Countries citing papers authored by Josh Lauring

Since Specialization

Citations

This map shows the geographic impact of Josh Lauring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josh Lauring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josh Lauring more than expected).

Fields of papers citing papers by Josh Lauring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josh Lauring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josh Lauring. The network helps show where Josh Lauring may publish in the future.

Co-authorship network of co-authors of Josh Lauring

This figure shows the co-authorship network connecting the top 25 collaborators of Josh Lauring. A scholar is included among the top collaborators of Josh Lauring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josh Lauring. Josh Lauring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morris, Michael J., Jeffrey Y.C. Wong, Luke T. Nordquist, et al.. (2024). A phase 1 study of JNJ-69086420 (JNJ-6420), an actinium-225 (²²⁵Ac) -labeled antibody targeting human kallikrein 2 (hK2), for metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 42(16_suppl). 5010–5010. 7 indexed citations

Li, Roger, Ja Hyeon Ku, Antoni Vilaseca, et al.. (2024). Urine-based testing for patient selection and genomic characterization of patients with FGFR alteration-positive non–muscle-invasive bladder cancer (NMIBC) treated with TAR-210.. Journal of Clinical Oncology. 42(4_suppl). 676–676. 1 indexed citations

Vilaseca, Antoni, Gautam Jayram, Carles X. Raventós, et al.. (2023). LBA104 First safety and efficacy results of the TAR-210 erdafitinib (erda) intravesical delivery system in patients (pts) with non–muscle-invasive bladder cancer (NMIBC) with select FGFR alterations (alt). Annals of Oncology. 34. S1343–S1343. 16 indexed citations

Sava, Georgina P., Caroline Huard, Letícia Meneguello, et al.. (2023). Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibition. Molecular Cell. 83(22). 4078–4092.e6. 26 indexed citations

Walsh, Elaine M., John H. Fetting, Deborah K. Armstrong, et al.. (2021). Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes. Clinical Breast Cancer. 22(4). 319–325. 8 indexed citations

Cushman‐Vokoun, Allison M., Josh Lauring, John D. Pfeifer, et al.. (2021). Laboratory and Clinical Implications of Incidental and Secondary Germline Findings During Tumor Testing. Archives of Pathology & Laboratory Medicine. 146(1). 70–77. 16 indexed citations

Vieito, María, Anna Spreafico, Víctor Moreno, et al.. (2020). 537MO First-in-human study of JNJ-64619178, a protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced cancers. Annals of Oncology. 31. S470–S470. 19 indexed citations

Croessmann, Sarah, Hong Yuen Wong, Daniel J. Zabransky, et al.. (2017). PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity. Breast Cancer Research and Treatment. 162(3). 451–464. 17 indexed citations

Lee, Justin, Jennifer E. Axilbund, W. Brian Dalton, et al.. (2016). A Polycythemia VeraJAK2Mutation Masquerading as a Duodenal Cancer Mutation. Journal of the National Comprehensive Cancer Network. 14(12). 1495–1498. 10 indexed citations

10.

Hu, Hai, Ashish Juvekar, Costas A. Lyssiotis, et al.. (2016). Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton. Cell. 164(3). 433–446. 289 indexed citations

11.

Toro, Patricia Valda, Bracha Erlanger, Julia A. Beaver, et al.. (2015). Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA. Clinical Biochemistry. 48(15). 993–998. 83 indexed citations

12.

Springer, Simeon, et al.. (2015). Engineering targeted chromosomal amplifications in human breast epithelial cells. Breast Cancer Research and Treatment. 152(2). 313–321. 2 indexed citations

13.

Beaver, Julia A., John P. Gustin, Kyung Hee Yi, et al.. (2013). PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System. Clinical Cancer Research. 19(19). 5413–5422. 76 indexed citations

14.

Lauring, Josh, Ben Ho Park, & Antonio C. Wolff. (2013). The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in Breast Cancer. Journal of the National Comprehensive Cancer Network. 11(6). 670–678. 92 indexed citations

15.

Higgins, Michaela J., Julia A. Beaver, Hong Yuen Wong, et al.. (2011). PIK3CAmutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells. Cancer Biology & Therapy. 11(3). 358–367. 7 indexed citations

16.

Kuo, Alex, Peggie Cheung, Kaifu Chen, et al.. (2011). NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming. Molecular Cell. 44(4). 609–620. 322 indexed citations

17.

Konishi, Hiroyuki, Bedri Karakas, Abde M. Abukhdeir, et al.. (2007). Knock-in of Mutant K- ras in Nontumorigenic Human Epithelial Cells as a New Model for Studying K- ras –Mediated Transformation. Cancer Research. 67(18). 8460–8467. 74 indexed citations

18.

Konishi, Hiroyuki, Josh Lauring, Joseph P. Garay, et al.. (2007). A PCR-based high-throughput screen with multiround sample pooling: application to somatic cell gene targeting. Nature Protocols. 2(11). 2865–2874. 17 indexed citations

19.

Lauring, Josh, et al.. (2003). A Conserved Transcriptional Enhancer Regulates RAG Gene Expression in Developing B Cells. Immunity. 19(1). 105–117. 122 indexed citations

20.

Wang, Qian‐Fei, Josh Lauring, & Mark S. Schlissel. (2000). c-Myb Binds to a Sequence in the Proximal Region of the RAG-2 Promoter and Is Essential for Promoter Activity in T-Lineage Cells. Molecular and Cellular Biology. 20(24). 9203–9211. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact